Activated Vγ9Vδ2 T Cells Trigger Granulocyte Functions via MCP-2 Release

被引:35
作者
Agrati, Chiara [1 ]
Cimini, Eleonora [1 ]
Sacchi, Alessandra [1 ]
Bordoni, Veronica [1 ]
Gioia, Cristiana [1 ]
Casetti, Rita [1 ]
Turchi, Federica [1 ]
Tripodi, Marco [1 ]
Martini, Federico [1 ]
机构
[1] Natl Inst Infect Dis Lazzaro Spallanzani, IRCCS, Rome, Italy
关键词
NONPEPTIDE ANTIGENS; MYCOBACTERIUM-TUBERCULOSIS; ANTIVIRAL IMMUNITY; ZOLEDRONIC ACID; CC CHEMOKINES; IN-VITRO; INFECTION; DEFENSINS; STIMULATION; LYMPHOCYTES;
D O I
10.4049/jimmunol.182.1.522
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
V gamma 9V delta 2 T cells display a broad antimicrobial activity by directly killing infected cells and by inducing an effective adaptive immune response. The activation of V gamma 9V delta 2 T cells by aminobisphosphonate drugs such as zoledronic acid (ZOL) results in a massive release of cytokines and chemokines that may induce a bystander activation of other immune cells. The aim of this work was to evaluate the ability of soluble factors released by ZOL-activated V gamma 9V delta 2 T cells to induce granulocyte activation. We showed that soluble factors released by ZOL-stimulated V gamma 9V delta 2 T cells activate granulocytes by inducing their chemotaxis, phagocytosis, and alpha-defensins release. Proteomic analysis allowed us to identify a number of cytokines and chemokines specifically released by activated V gamma 9V delta 2 T cells. Moreover, MCP-2 depletion by neutralizing Ab revealed a critical role of this chemokine in induction of granulocyte alpha-defensins release. Altogether, these data show a V gamma 9V delta 2-mediated activation of granulocytes through a bystander mechanism, and confirm the wide ability of V gamma 9V delta 2 T-lymphocytes in orchestrating the immune response. In conclusion, an immune modulating strategy targeting V gamma 9V delta 2 T cells may represent a key switch to induce an effective and well-coordinated immune response, and can be proposed as a way to strengthen the immune competence during infectious diseases. The Journal of Immunology, 2009, 182: 522-529.
引用
收藏
页码:522 / 529
页数:8
相关论文
共 50 条
  • [31] Aminobisphosphonates Synergize with Human Cytomegalovirus To Activate the Antiviral Activity of Vγ9Vδ2 Cells
    Daguzan, Charline
    Moulin, Morgane
    Kulyk-Barbier, Hanna
    Davrinche, Christian
    Peyrottes, Suzanne
    Champagne, Eric
    JOURNAL OF IMMUNOLOGY, 2016, 196 (05) : 2219 - 2229
  • [32] Targeting BTN2A1 Enhances Vγ9Vδ2 T-Cell Effector Functions and Triggers Tumor Cell Pyroptosis
    Le Floch, Anne-Charlotte
    Imbert, Caroline
    Boucherit, Nicolas
    Gorvel, Laurent
    Fattori, Stephane
    Orlanducci, Florence
    Le Roy, Aude
    Archetti, Lorenzo
    Crescence, Lydie
    Panicot-Dubois, Laurence
    Dubois, Christophe
    Vey, Norbert
    Briantais, Antoine
    Anastasio, Amandine
    Cano, Carla
    Guittard, Geoffrey
    Frechin, Mathieu
    Olive, Daniel
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (12) : 1677 - 1690
  • [33] Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL-NKG2D Axis
    Wang, Zhan
    Wang, Zenan
    Li, Shu
    Li, Binghao
    Sun, Lingling
    Li, Hengyuan
    Lin, Peng
    Wang, Shengdong
    Teng, Wangsiyuan
    Zhou, Xingzhi
    Ye, Zhaoming
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [34] The effects of systemic treatment with aminobisphosphonates and statins on circulating Vγ9Vδ2-T cells in patients with advanced cancer
    Schneiders, Famke L.
    Huijts, Charlotte M.
    Reijm, Martine
    Bontkes, Hetty J.
    Verheul, Henk M. W.
    de Gruijl, Tanja D.
    van der Vliet, Hans J.
    IMMUNOBIOLOGY, 2018, 223 (02) : 171 - 177
  • [35] Emerging Challenges of Preclinical Models of Anti-tumor Immunotherapeutic Strategies Utilizing Vγ9Vδ2 T Cells
    Joalland, Noemie
    Scotet, Emmanuel
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [36] Vγ9Vδ2 T cell activation by strongly agonistic nucleotidic phosphoantigens
    Moulin, Morgane
    Alguacil, Javier
    Gu, Siyi
    Mehtougui, Asmaa
    Adams, Erin J.
    Peyrottes, Suzanne
    Champagne, Eric
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2017, 74 (23) : 4353 - 4367
  • [37] Butyrophilin3A proteins and Vγ9Vδ2 T cell activation
    Gu, Siyi
    Borowska, Marta T.
    Boughter, Christopher T.
    Adams, Erin J.
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2018, 84 : 65 - 74
  • [38] Generation of Stable Isopentenyl Monophosphate Aryloxy Triester Phosphoramidates as Activators of Vγ9Vδ2 T Cells
    Xu, Qin
    Taher, Taher E.
    Ashby, Elizabeth
    Sharif, Maria
    Willcox, Benjamin E.
    Mehellou, Youcef
    CHEMMEDCHEM, 2021, 16 (15) : 2375 - 2380
  • [39] Human Vγ9Vδ2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts
    Gertner-Dardenne, Julie
    Castellano, Remy
    Mamessier, Emilie
    Garbit, Slaveia
    Kochbati, Eloise
    Etienne, Anne
    Charbonnier, Aude
    Collette, Yves
    Vey, Norbert
    Olive, Daniel
    JOURNAL OF IMMUNOLOGY, 2012, 188 (09) : 4701 - 4708
  • [40] Sensitization of human osteosarcoma cells to Vγ9Vδ2 T-cell-mediated cytotoxicity by zoledronate
    Li, Zhaoxu
    Peng, Huiqin
    Xu, Qiang
    Ye, Zhaoming
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2012, 30 (05) : 824 - 830